History | Harmful sexual behaviour among children and young people | Guidance | NICE

Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
View all What we do
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

History

Equality and health inequalities assessment

Equality impact assessment (PDF 326 KB)

Published:

20 September 2016

Document finalisation

Consultation comments and responses (PDF 1.15 MB)

Published:

20 September 2016

Committee list updated

Committee member list (PDF 111 KB)

Published:

13 June 2016

Draft guidance consultation

Draft guidance consultation
Draft guideline (PDF 495 KB)

Published:

24 February 2016
Equality impact assessment (PDF 178 KB)

Published:

24 February 2016
Committee member list (PDF 111 KB)

Published:

24 February 2016
Evidence review 1 (PDF 2.14 MB)

Published:

24 February 2016
Evidence review 2 (PDF 1.55 MB)

Published:

24 February 2016
Confidentiality form (MSWord 42 KB)

Published:

25 February 2016
Economic report (PDF 1.17 MB)

Published:

26 February 2016
Expert report Papers 1 - 4 (PDF 431 KB)

Published:

29 February 2016
Expert report Papers 5 - 8 (PDF 537 KB)

Published:

29 February 2016
Expert report Papers 9 - 12 (PDF 423 KB)

Published:

29 February 2016
Comments form (MSWord 83 KB)

Published:

06 April 2016

Scope finalisation

Economic plan (PDF 98 KB)

Published:

14 January 2016
Review protocols (PDF 214 KB)

Published:

14 January 2016

Stakeholder list updated

Stakeholder list (PDF 117 KB)

Published:

14 June 2016

Committee meetings

Committee meeting
Minutes 13 May 2015 (PDF 254 KB)

Published:

20 November 2015
Minutes 30 Jun 2015 (PDF 203 KB)

Published:

20 November 2015
Minutes 09 Sept 2015 (PDF 173 KB)

Published:

20 November 2015
Minutes 13 Oct 2015 (PDF 159 KB)

Published:

13 January 2016
Minutes 9 & 10 May 2016 (PDF 170 KB)

Published:

20 September 2016
Minutes 24 & 25 Nov 2015 (PDF 362 KB)

Published:

20 September 2016

Call for evidence 2

Call for evidence 2 information

Call for evidence

Call for evidence information
Stakeholder response (unpublished material) (MSWord 57 KB)

Published:

03 December 2014
Stakeholder response (published material) (MSWord 57 KB)

Published:

03 December 2014

Sexually harmful behaviour among young people: scope consultation

Sexually harmful behaviour among young people: scope consultation information
Draft scope stakeholder comments and responses table (PDF 1.26 MB)

Published:

02 December 2014
Sexually harmful behaviour among young people: final scope (PDF 119 KB)

Published:

03 December 2014
Sexually harmful behaviour among young people: draft scope (PDF 216 KB)

Published:

23 September 2014

PHAC member list and declaration of interests

PHAC member list and declaration of interests (PDF 198 KB)

Published:

13 July 2015